Ten big lobbying groups turn their guns on Allergan's controversial patent gambit
Ten of the biggest healthcare lobbying groups in Washington, DC have joined the growing forces lined up against Allergan’s patent gambit involving Restasis.
In a letter to Congress, the alliance — which includes the American Hospital Association and America’s Health Insurance Plans — blasted Allergan $AGN for putting profits ahead of patients and put their CEO in the same camp with notorious biopharma bad boy Martin Shkreli, the price-gouging exec at Turing who’s now chilling in a federal prison awaiting sentencing on three felony convictions.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.